Kenvue (KVUE) Stock Price, News & Analysis

Company Overview

Kenvue (NYSE:KVUE) is a global consumer health company that was established in 2023 following its separation from Johnson & Johnson. The company houses a portfolio of well-known over-the-counter and personal care brands, carrying forward a legacy that spans more than a century of innovation in health and wellness. With its headquarters in New Brunswick, New Jersey, Kenvue began independent trading as part of a strategic move to focus solely on consumer health products while leveraging the deep brand equity and research capabilities inherited from its predecessor.

The company’s product offerings span several core categories, including pain relief, skin health, oral care, baby care and women’s health. Signature brands under the Kenvue umbrella include Tylenol, Neutrogena, Aveeno, Listerine and Johnson’s Baby. Kenvue’s portfolio also encompasses digestive health solutions and nutritional supplements, backed by a focus on science-driven formulation and consumer-focused innovation. Research and development efforts target both the enhancement of existing product lines and the introduction of new offerings that address emerging health and wellness trends.

Operating in more than 100 countries, Kenvue employs a multi-channel distribution strategy that includes retail pharmacies, mass merchandisers, grocery chains and e-commerce platforms. The company’s global supply chain is supported by manufacturing facilities and partnerships across North America, Europe, Asia-Pacific and Latin America. Kenvue places emphasis on expanding access to affordable healthcare products in emerging markets while optimizing its footprint in established markets through sustainable sourcing and packaging initiatives.

Leadership at Kenvue is headed by Chief Executive Officer Thibaut Mongon, whose background in consumer products and healthcare drives the company’s strategic direction. The senior management team brings decades of combined experience in brand management, product innovation and global operations. Kenvue’s governance framework emphasizes environmental, social and corporate responsibility, with objectives that include reducing carbon emissions, enhancing supply chain transparency and supporting community health programs worldwide.

Key Stats

• Today's Range: $21.29 to $21.92
• 50-Day Range: $20.71 to $24.47
• 52-Week Range: $17.85 to $25.17
• Volume: 21.83 million shs
• Average Volume: 16.33 million shs
• Market Capitalization: $41.91 billion
• P/E Ratio: 39.72
• Dividend Yield: 3.75%
• Price Target: $24.88
• Consensus Rating: Hold

Kenvue Stock Analysis - MarketRank™

Kenvue scored higher than 65% of companies evaluated by MarketBeat, and ranked 86th out of 154 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.2 / 5
• Analyst Rating: Hold

Consensus Rating

Kenvue has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on 5 buy ratings, 7 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Kenvue has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 8.77%

Earnings Growth

Earnings for Kenvue are expected to grow by 8.77% in the coming year, from $1.14 to $1.24 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Kenvue is 39.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.71.

Price to Earnings Ratio vs. Sector

The P/E ratio of Kenvue is 39.72, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 19.70.

Price to Earnings Growth Ratio

Kenvue has a PEG Ratio of 3.39. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Kenvue has a P/B Ratio of 4.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.53% of the float of Kenvue has been sold short.

Short Interest Ratio / Days to Cover

Kenvue has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Kenvue has recently decreased by 9.51%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Kenvue is a leading dividend payer. It pays a dividend yield of 3.76%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Kenvue has only been increasing its dividend for 1 years.

Dividend Coverage

The dividend payout ratio of Kenvue is 149.09%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Kenvue will have a dividend payout ratio of 66.13% next year. This indicates that Kenvue will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.53% of the float of Kenvue has been sold short.

Short Interest Ratio / Days to Cover

Kenvue has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Kenvue has recently decreased by 9.51%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.64

News Sentiment

Kenvue has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 51 news articles for Kenvue this week, compared to 20 articles on an average week.

Search Interest

28 people have searched for KVUE on MarketBeat in the last 30 days. This is an increase of 40% compared to the previous 30 days.

MarketBeat Follows

Only 6 people have added Kenvue to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Kenvue insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.17% of the stock of Kenvue is held by insiders.

Percentage Held by Institutions

97.64% of the stock of Kenvue is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

KVUE Stock Analysis - Frequently Asked Questions

How have KVUE shares performed this year?

Kenvue's stock was trading at $21.35 at the start of the year. Since then, KVUE stock has increased by 2.3% and is now trading at $21.8450.

How were Kenvue's earnings last quarter?

Kenvue Inc. (NYSE:KVUE) issued its quarterly earnings results on Thursday, May, 8th. The company reported $0.24 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. The firm's quarterly revenue was down 3.9% on a year-over-year basis.
Read the conference call transcript.

When did Kenvue IPO?

Kenvue (KVUE) raised $3.3 billion in an IPO on Thursday, May 4th 2023. The company issued 151,200,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank acted as the underwriters for the IPO.

Who are Kenvue's major shareholders?

Top institutional shareholders of Kenvue include Assenagon Asset Management S.A. (0.40%), MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH (0.07%), Thomasville National Bank (0.04%) and Public Employees Retirement System of Ohio (0.03%).
View institutional ownership trends.

How do I buy shares of Kenvue?

Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Kenvue own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Kenvue investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), AU Optronics (AUOTY), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 5/08/2025
• Record date for 5/28 Dividend: 5/14/2025
• Ex-Dividend for 5/28 Dividend: 5/14/2025
• Dividend Payable: 5/28/2025
• Today: 7/16/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: CONS PD - MISC STPL
• Sub-Industry: Consumer Goods
• Current Symbol: NYSE:KVUE
• CIK: 1944048
• Web: www.kenvue.com
• Phone: (732) 524-0400
• Fax: N/A
• Employees: 22,000
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Kenvue: $24.88
• High Price Target: $29.00
• Low Price Target: $22.00
• Potential Upside/Downside: +13.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.42
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.55
• Trailing P/E Ratio: 39.72
• Forward P/E Ratio: 19.16
• P/E Growth: 3.39
• Net Income: $1.03 billion
• Net Margins: 6.90%
• Pretax Margin: 9.45%
• Return on Equity: 20.87%
• Return on Assets: 8.04%

Debt

• Debt-to-Equity Ratio: 0.63
• Current Ratio: 0.86
• Quick Ratio: 0.60

Sales & Book Value

• Annual Sales: $15.46 billion
• Price / Sales: 2.71
• Cash Flow: $1.47 per share
• Price / Cash Flow: 14.83
• Book Value: $5.04 per share
• Price / Book: 4.33

Miscellaneous

• Outstanding Shares: 1,918,690,000
• Free Float: 1,915,429,000
• Market Cap: $41.91 billion
• Optionable: Optionable
• Beta: 0.83